A cannabis-derived medicine may soon become the first to be approved by FDA. Then CBD would probably be reclassified by the DEA within 90 days. This article from The Washington Post sheds more light. At 3 months old, Marissa Parsons began having frequent seizures, some lasting a half-hour. For almost two decades, her desperate parents tried drug after drug to treat her rare ... Continue Reading